Company intelligence / Profile preview

Bovotica

Brisbane, Queensland, Australia

Ownership: Private
Development stage: Preclinical

Overview

Bovotica is developing a proprietary probiotic/prebiotic feed supplement that modulates the bovine rumen microbiome. Early research shows this approach can reduce methane emissions from cattle while improving production efficiency by increasing short-chain fatty acid production. The company is collaborating with industry partners for further validation but has not yet reported clinical or field trial results.

Therapeutic areas: Other
Modalities: Probiotic feed supplementPrebiotic feed supplementMicrobial therapy
Industry: Agriculture & AgTech

Partnerships

Australian Country Choice (ACC) – collaboration for research samples and biobank development

Beyond the preview

Go deeper on Bovotica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bovotica.

Explore the full profile